<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35581240</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Nuclear RNA transcript levels modulate nucleocytoplasmic distribution of ALS/FTD-associated protein FUS.</ArticleTitle><Pagination><StartPage>8180</StartPage><MedlinePgn>8180</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8180</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-12098-4</ELocationID><Abstract><AbstractText>Fused in Sarcoma (FUS) is a nuclear RNA/DNA binding protein that mislocalizes to the cytoplasm in the neurodegenerative diseases ALS and FTD. Despite the existence of FUS pathogenic mutations that result in nuclear import defects, a subset of ALS/FTD patients display cytoplasmic accumulation of wild-type FUS, although the underlying mechanism is unclear. Here we confirm that transcriptional inhibition, specifically of RNA polymerase II (RNAP II), induces FUS cytoplasmic translocation, but we show that several other stresses do not. We found unexpectedly that the epitope specificity of different FUS antibodies significantly affects the apparent FUS nucleocytoplasmic ratio as determined by immunofluorescence, explaining inconsistent observations in previous studies. Significantly, depletion of the nuclear mRNA export factor NXF1 or RNA exosome cofactor MTR4 promotes FUS nuclear retention, even when transcription is repressed, while mislocalization was independent of the nuclear protein export factor CRM1 and import factor TNPO1. Finally, we report that levels of nascent RNAP II transcripts, including those known to bind FUS, are reduced in sporadic ALS iPS cells, linking possible aberrant transcriptional control and FUS cytoplasmic mislocalization. Our findings thus reveal that factors that influence accumulation of nuclear RNAP II transcripts modulate FUS nucleocytoplasmic homeostasis, and provide evidence that reduced RNAP II transcription can contribute to FUS mislocalization to the cytoplasm in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yueh-Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Yu Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manley</LastName><ForeName>James L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Columbia University, New York, NY, 10027, USA. jlm2@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM118136</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM118136</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015138">RNA, Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015138" MajorTopicYN="N">RNA, Nuclear</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="Y">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35581240</ArticleId><ArticleId IdType="pmc">PMC9114323</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-12098-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-12098-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang WY, et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat. Neurosci. 2013;16:1383&#x2013;1391. doi: 10.1038/nn.3514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Reed R. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP. Proc. Natl. Acad. Sc.i USA. 2015;112:8608&#x2013;8613. doi: 10.1073/pnas.1506282112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1506282112</ArticleId><ArticleId IdType="pmc">PMC4507187</ArticleId><ArticleId IdType="pubmed">26124092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Gal J, Chen J, Zhu H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl. Acad. Sci. USA. 2014;111:17809&#x2013;17814. doi: 10.1073/pnas.1414004111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1414004111</ArticleId><ArticleId IdType="pmc">PMC4273402</ArticleId><ArticleId IdType="pubmed">25453086</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin H, et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120:33&#x2013;41. doi: 10.1007/s00401-010-0698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0698-6</ArticleId><ArticleId IdType="pmc">PMC2887939</ArticleId><ArticleId IdType="pubmed">20490813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack GE, et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain. 2019;142:2572&#x2013;2580. doi: 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132:2922&#x2013;2931. doi: 10.1093/brain/awp214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp214</ArticleId><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RR, et al. FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress. J. Cell Physiol. 2013;228:2222&#x2013;2231. doi: 10.1002/jcp.24395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24395</ArticleId><ArticleId IdType="pmc">PMC4000275</ArticleId><ArticleId IdType="pubmed">23625794</ArticleId></ArticleIdList></Reference><Reference><Citation>Hock EM, et al. Hypertonic stress causes cytoplasmic translocation of neuronal, but not astrocytic, FUS due to impaired transportin function. Cell Rep. 2018;24:987&#x2013;1000.E1007. doi: 10.1016/j.celrep.2018.06.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.094</ArticleId><ArticleId IdType="pubmed">30044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischbein M, et al. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing. J. Biol. Chem. 2019;294:10194&#x2013;10210. doi: 10.1074/jbc.RA118.005933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005933</ArticleId><ArticleId IdType="pmc">PMC6664169</ArticleId><ArticleId IdType="pubmed">31092554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M, et al. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 2000;29:652&#x2013;658. doi: 10.1016/s0891-5849(00)00349-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0891-5849(00)00349-x</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Konopka A, Soo KY, Ito D, Atkin JD. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2017;26:2882&#x2013;2896. doi: 10.1093/hmg/ddx170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan K, et al. Uncovering pathophysiological changes in frontotemporal dementia using serum lipids. Sci. Rep. 2020;10:3640. doi: 10.1038/s41598-020-60457-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-60457-w</ArticleId><ArticleId IdType="pmc">PMC7046653</ArticleId><ArticleId IdType="pubmed">32107421</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q, et al. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage. J. Neurosci. 2014;34:7802&#x2013;7813. doi: 10.1523/JNEUROSCI.0172-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0172-14.2014</ArticleId><ArticleId IdType="pmc">PMC4044245</ArticleId><ArticleId IdType="pubmed">24899704</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads SN, et al. The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization. Mol. Biol. Cell. 2018;29:1786&#x2013;1797. doi: 10.1091/mbc.E17-12-0735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-12-0735</ArticleId><ArticleId IdType="pmc">PMC6085830</ArticleId><ArticleId IdType="pubmed">29897835</ArticleId></ArticleIdList></Reference><Reference><Citation>Singatulina AS, et al. PARP-1 activation directs FUS to DNA damage sites to form PARG-reversible compartments enriched in damaged DNA. Cell Rep. 2019;27:1809&#x2013;1821.E1805. doi: 10.1016/j.celrep.2019.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.031</ArticleId><ArticleId IdType="pubmed">31067465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Immanuel D, Yin Y, Liang FX, Ron D. A topogenic role for the oncogenic N-terminus of TLS: Nucleolar localization when transcription is inhibited. Oncogene. 1997;14:451&#x2013;461. doi: 10.1038/sj.onc.1200854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1200854</ArticleId><ArticleId IdType="pubmed">9053842</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Albalat R, Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 1994;8:2513&#x2013;2526. doi: 10.1101/gad.8.21.2513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.8.21.2513</ArticleId><ArticleId IdType="pubmed">7958914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, et al. Nuclear egress of TDP-43 and FUS occurs independently of exportin-1/CRM1. Sci. Rep. 2018;8:7084. doi: 10.1038/s41598-018-25007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25007-5</ArticleId><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J, et al. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis. Model Mech. 2015;8:755&#x2013;766. doi: 10.1242/dmm.020099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.020099</ArticleId><ArticleId IdType="pmc">PMC4486861</ArticleId><ArticleId IdType="pubmed">26035390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K, Suzuki H, Aiso S, Matsuoka M. ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol. Neurobiol. 2009;39:81&#x2013;89. doi: 10.1007/s12035-009-8054-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-009-8054-3</ArticleId><ArticleId IdType="pubmed">19184563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128:505&#x2013;524. doi: 10.1007/s00401-014-1336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1336-5</ArticleId><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Piccolo L, Mochizuki H, Nagai Y. The lncRNA hsromega regulates arginine dimethylation of human FUS to cause its proteasomal degradation in Drosophila. J. Cell Sci. 2019 doi: 10.1242/jcs.236836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.236836</ArticleId><ArticleId IdType="pmc">PMC6826006</ArticleId><ArticleId IdType="pubmed">31519807</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA. 2009;106:7607&#x2013;7612. doi: 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Yokoshi M, Okada H, Kawahara Y. The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat. Commun. 2015;6:6183. doi: 10.1038/ncomms7183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7183</ArticleId><ArticleId IdType="pubmed">25630387</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner M, Lopato S, Gotzmann J, Sauermann G, Barta A. Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp. Cell Res. 2003;283:184&#x2013;195. doi: 10.1016/s0014-4827(02)00046-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-4827(02)00046-0</ArticleId><ArticleId IdType="pubmed">12581738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Embree LJ, Tsai S, Hickstein DD. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 1998;273:27761&#x2013;27764. doi: 10.1074/jbc.273.43.27761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.43.27761</ArticleId><ArticleId IdType="pubmed">9774382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarskjold ML, Rekosh D. SR proteins: To shuttle or not to shuttle, that is the question. J. Cell Biol. 2017;216:1875&#x2013;1877. doi: 10.1083/jcb.201705009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201705009</ArticleId><ArticleId IdType="pmc">PMC5496630</ArticleId><ArticleId IdType="pubmed">28600433</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Gattoni R, Stevenin J, Steitz JA. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol. Cell. 2003;11:837&#x2013;843. doi: 10.1016/s1097-2765(03)00089-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1097-2765(03)00089-3</ArticleId><ArticleId IdType="pubmed">12667464</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller-McNicoll M, et al. SR proteins are NXF1 adaptors that link alternative RNA processing to mRNA export. Genes Dev. 2016;30:553&#x2013;566. doi: 10.1101/gad.276477.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.276477.115</ArticleId><ArticleId IdType="pmc">PMC4782049</ArticleId><ArticleId IdType="pubmed">26944680</ArticleId></ArticleIdList></Reference><Reference><Citation>Meola N, et al. Identification of a nuclear exosome decay pathway for processed transcripts. Mol. Cell. 2016;64:520&#x2013;533. doi: 10.1016/j.molcel.2016.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.09.025</ArticleId><ArticleId IdType="pubmed">27871484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogami K, et al. An Mtr4/ZFC3H1 complex facilitates turnover of unstable nuclear RNAs to prevent their cytoplasmic transport and global translational repression. Genes Dev. 2017;31:1257&#x2013;1271. doi: 10.1101/gad.302604.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.302604.117</ArticleId><ArticleId IdType="pmc">PMC5558927</ArticleId><ArticleId IdType="pubmed">28733371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretov DA, et al. Inhibition of transcription induces phosphorylation of YB-1 at Ser102 and Its accumulation in the nucleus. Cells. 2019 doi: 10.3390/cells9010104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010104</ArticleId><ArticleId IdType="pmc">PMC7016903</ArticleId><ArticleId IdType="pubmed">31906126</ArticleId></ArticleIdList></Reference><Reference><Citation>Stommel JM, et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking. EMBO J. 1999;18:1660&#x2013;1672. doi: 10.1093/emboj/18.6.1660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.6.1660</ArticleId><ArticleId IdType="pmc">PMC1171253</ArticleId><ArticleId IdType="pubmed">10075936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutka SC, et al. Identification of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res. 2009;69:510&#x2013;517. doi: 10.1158/0008-5472.CAN-08-0858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-0858</ArticleId><ArticleId IdType="pmc">PMC2635062</ArticleId><ArticleId IdType="pubmed">19147564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka K, et al. Characteristic features of FUS inclusions in spinal motor neurons of sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2020;79:370&#x2013;377. doi: 10.1093/jnen/nlaa003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa003</ArticleId><ArticleId IdType="pubmed">32142134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank EM, et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:2845. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, et al. Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in amyotrophic lateral sclerosis. Cell Rep. 2019;27:3818&#x2013;3831.e3815. doi: 10.1016/j.celrep.2019.05.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.085</ArticleId><ArticleId IdType="pmc">PMC6613039</ArticleId><ArticleId IdType="pubmed">31242416</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T, et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010;74:366&#x2013;371. doi: 10.1212/WNL.0b013e3181ccc732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ccc732</ArticleId><ArticleId IdType="pubmed">20124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Laubenthal J, Hermann A. Fused in sarcoma-amyotrophic lateral sclerosis as a novel member of DNA single strand break diseases with pure neurological phenotypes. Neural Regen. Res. 2021;16:110&#x2013;112. doi: 10.4103/1673-5374.286963.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.286963</ArticleId><ArticleId IdType="pmc">PMC7818870</ArticleId><ArticleId IdType="pubmed">32788458</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 2016;132:175&#x2013;196. doi: 10.1007/s00401-016-1575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1575-8</ArticleId><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 2015;6:6171. doi: 10.1038/ncomms7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7171</ArticleId><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T, Alexiou P, Maragkakis M, Chang A, Mourelatos Z. FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns. RNA. 2013;19:498&#x2013;509. doi: 10.1261/rna.037804.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.037804.112</ArticleId><ArticleId IdType="pmc">PMC3677260</ArticleId><ArticleId IdType="pubmed">23389473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman B, Ron M, Mikl M, Segal E, Ulitsky I. Gene architecture and sequence composition underpin selective dependency of nuclear export of long RNAs on NXF1 and the TREX complex. Mol. Cell. 2020;79:251&#x2013;267.e256. doi: 10.1016/j.molcel.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.05.013</ArticleId><ArticleId IdType="pubmed">32504555</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Schwartz JC, Cech TR. Nucleic acid-binding specificity of human FUS protein. Nucleic Acids Res. 2015;43:7535&#x2013;7543. doi: 10.1093/nar/gkv679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv679</ArticleId><ArticleId IdType="pmc">PMC4551922</ArticleId><ArticleId IdType="pubmed">26150427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, et al. Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity. Cell Rep. 2018;24:529&#x2013;537524. doi: 10.1016/j.celrep.2018.06.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.070</ArticleId><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, et al. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. Plos Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotti D, et al. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway. Mol. Cell Biol. 2000;20:6159&#x2013;6169. doi: 10.1128/mcb.20.16.6159-6169.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.20.16.6159-6169.2000</ArticleId><ArticleId IdType="pmc">PMC86091</ArticleId><ArticleId IdType="pubmed">10913197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, et al. Cdc48/VCP and endocytosis regulate TDP-43 and FUS toxicity and turnover. Mol. Cell Biol. 2020 doi: 10.1128/MCB.00256-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00256-19</ArticleId><ArticleId IdType="pmc">PMC6996276</ArticleId><ArticleId IdType="pubmed">31767634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu S, Liu G, Ozturk A, Hicks GG. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9:e1003895. doi: 10.1371/journal.pgen.1003895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003895</ArticleId><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 2007;27:10530&#x2013;10534. doi: 10.1523/JNEUROSCI.3421-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3421-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673167</ArticleId><ArticleId IdType="pubmed">17898224</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J. Neurochem. 2009;110:1082&#x2013;1094. doi: 10.1111/j.1471-4159.2009.06211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06211.x</ArticleId><ArticleId IdType="pubmed">19522733</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz JC, et al. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 2012;26:2690&#x2013;2695. doi: 10.1101/gad.204602.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.204602.112</ArticleId><ArticleId IdType="pmc">PMC3533074</ArticleId><ArticleId IdType="pubmed">23249733</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, et al. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife. 2016 doi: 10.7554/eLife.17820.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018 doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Conlon EG, Manley JL, Rio DC. Widespread intron retention impairs protein homeostasis in C9orf72 ALS brains. Genome Res. 2020;30:1705&#x2013;1715. doi: 10.1101/gr.265298.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.265298.120</ArticleId><ArticleId IdType="pmc">PMC7706729</ArticleId><ArticleId IdType="pubmed">33055097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai YL, et al. ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes Dev. 2020;34:785&#x2013;805. doi: 10.1101/gad.335836.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.335836.119</ArticleId><ArticleId IdType="pmc">PMC7263147</ArticleId><ArticleId IdType="pubmed">32381627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature. 2011;474:390&#x2013;394. doi: 10.1038/nature10006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10006</ArticleId><ArticleId IdType="pmc">PMC3117022</ArticleId><ArticleId IdType="pubmed">21572438</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>